Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Director departure
|
|
Zivo Bioscience, Inc. (ZIVO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 07/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...|
Docs:
|
"Form of Placement Agent Agreement",
"Form of Series A Common Warrant",
"Form of Series B Common Warrant",
"Form of Pre-Funded Warrant",
"Opinion of Fennemore Craig, P.C",
"Opinion of Honigman LLP",
"Form of Securities Purchase Agreement, by and between Zivo Biosciences, Inc. and the Investor",
"ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market" |
|
| 06/15/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/26/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 04/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Note",
"Warrant",
"Subscription Agreement",
"ZIVO Bioscience Receives $1 Million Bridge Financing BLOOMFIELD HILLS, Mich. – Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced a $1 million unsecured six-month loan from its Chairman, Chief Executive Officer, and President, John Payne. The loan carries 10% simple interest, may be prepaid without penalty, is extendable for an additional six months and includes warrants to purchase 390,000 shares of ZIVO common stock with a strike price of $2.91 per share. More information on the loan and warrants is available in ZIVO’s Form 8-K filed today with the SEC. ZIVO Bioscience intends to use the proceeds from this bridge financing for working capital ..." |
|
| 02/10/2023 |
8-K
| Quarterly results |
| 11/29/2022 |
8-K
| Quarterly results |
| 08/23/2022 |
8-K
| Quarterly results |
| 08/03/2022 |
8-K
| Quarterly results |
| 07/07/2022 |
8-K
| Quarterly results |
| 06/28/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
8-K
| Quarterly results |
| 04/25/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...|
Docs:
|
"Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq BLOOMFIELD HILLS, Mich., – ZIVO Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that it received a Notice from Nasdaq that the Company has regained compliance of Nasdaq Listing Rule 5250. On April 19, 2022, the Company received a standard notice of noncompliance from Nasdaq indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission the Company was not in compliance with Nasdaq Listing Rule 5250, which requires timely filing of all required periodic fina..." |
|
| 04/15/2022 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review  ... |
| 03/01/2022 |
8-K/A
| Quarterly results |
| 02/25/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/16/2022 |
8-K
| Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
| 12/09/2021 |
8-K/A
| Quarterly results |
| 12/09/2021 |
8-K
| Quarterly results |
| 10/14/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/12/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/21/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/16/2021 |
8-K/A
| Quarterly results |
| 06/02/2021 |
8-K
| Quarterly results |
| 03/17/2021 |
8-K
| Quarterly results |
| 02/12/2021 |
8-K
| Quarterly results |
| 01/07/2021 |
8-K
| Quarterly results |
| 11/17/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 11/12/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/10/2020 |
8-K
| Quarterly results |
| 03/09/2020 |
8-K
| Quarterly results |
| 12/05/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/07/2019 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 05/01/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|